Corpus Intelligence IC Memo — BLADEN COUNTY HOSPITAL 2026-04-26 15:58 UTC
IC Memo — BLADEN COUNTY HOSPITAL
Investment Committee Memorandum | NC | 25 beds | Grade C | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BLADEN COUNTY HOSPITAL

CCN 341315 | BLADEN, NC | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BLADEN COUNTY HOSPITAL is a 25-bed suburban community hospital in BLADEN, NC with $37.8M in net patient revenue and a 2.1% operating margin. The hospital serves a payer mix of 35.3% Medicare, 6.8% Medicaid, and 57.9% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.1% to 9.4% (+736bps).

Net Revenue HCRIS$37.8M
Current EBITDA COMPUTED$781K
Operating Margin COMPUTED2.1%
Occupancy HCRIS61.3%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS33.7%
Distress Probability ML46.2%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
38
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 2.1% places it above the state median. Among 38 size-comparable peers (12-50 beds), the median margin is -5.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BLADEN COUNTY HOSPITAL (Target)NC25$37.8M2.1%
DAVIE MEDICAL CENTERNC42$108.5M27.5%
NOVANT HEALTH MINT HILL MEDICANC36$107.8M9.7%
THE OUTER BANKS HOSPITALNC21$93.7M26.2%
MEDICAL PARK HOSPITALNC22$82.6M15.8%
GRANVILLE MEDICAL CENTERNC42$81.5M-5.4%
NORTH CAROLINA SPECIALTY HOSPINC18$71.6M11.7%
CAPE FEAR VALLEY HOKE HOSPITALNC41$71.5M19.3%
THE MCDOWELL HOSPITALNC30$65.7M-6.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$793K+210bp18mo
Cost to Collect4.5%2.5%$755K+200bp12mo
Denial Rate Reduction12.0%6.5%$748K+198bp12mo
A/R Days Reduction5200.0%3800.0%$459K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$793K
Cost to Collect
$755K
Denial Rate Reduction
$748K
A/R Days Reduction
$459K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$781K
+ RCM Uplift+$2.8M
Pro Forma EBITDA$3.6M
Current Margin2.1%
Pro Forma Margin9.4%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.2M$32.9M27.40x93.9%
Base (11x exit)10.0x11.0x$1.2M$36.6M30.47x98.0%
Bull Case9.0x11.0x$1.1M$46.2M42.69x111.9%
Bull (12x exit)9.0x12.0x$1.1M$50.7M46.87x115.9%
Bear Case11.0x10.0x$1.3M$18.7M14.11x69.8%
Bear (11x exit)11.0x11.0x$1.3M$21.0M15.85x73.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 12-50 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-22.6% / P50=-5.4% / P75=5.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.